Clinical Trials Logo

Clinical Trial Summary

In this study the investigators want to investigate to what extent the application of an artificial bone flape (space flap) influences the success of a decompressive craniectomy. In all participants, a space flap is placed immediately after removal of the skull cap. In a second operation, after 1-3 months, an operation is performed, in which the stored own skull bone is re-inserted. The artificial bone cover is removed at this point.


Clinical Trial Description

The destruction of local brain parenchyma after cerebral infarction leads to local swelling within a few days. In the beginning the ischemic brain expand at the expense of the CSF and venous spaces. However, once these spaces are partially displaced further swelling invariably leads to increase of the intracranial pressure due to the limited space available inside the cranial vault. In cases of large infarctions this increase in intracranial pressure (ICP) may entail life threatening secondary injuries to the brain. The surgical removal of a large part of the skull (decompressive hemi-craniectomy) allows the ischemic brain to expand, therefore avoiding an increase of ICP and it's deleterious effects. After removal of a part of the skull the skin is closed again, and the skull flap is kept in sterile environment. Several months after decompression craniectomy patients undergo implantation of either their preserved bone flap or of a bone flap substitute (so-called patient specific implant, or PSI, mostly made out of Palacos®). Decompressive hemi-craniectomy comes at a cost for the patient, despite its undisputed role as a life saving surgery after large cerebral infarction. During the first days after surgery the brain may use the space freed up by bone removal. In some cases the brain may prolapse even further out of the cranial vault, leading to brain herniation. Brain herniation are common and may lead to further damage due to axonal shearing injuries in the brain, and to hemorrhages and infarction at the craniotomy edges. The lack of the protective skull prior to re-implantation of the bone flap puts the brain at risk of injuries due to falls during rehabilitation and exposes the brain indirectly to atmospheric pressure. Various neurological deficits subsumed as the syndrome of the trephined have been described in these patients. The symptoms of the syndrome of the trephined have in common that they appear a few weeks after decompression and significantly improve after re-implantation of the patient's own bone. The symptoms range from orthostatic headache and dizziness to motor paresis, aphasia, cognitive decline and brainstem compression symptoms. The pathophysiology behind the syndrome of the trephined can be understood as an "open box" phenomenon. After removal of the bone the brain is separated from the atmospheric pressure only by the skin. The skin, however, does not hold against atmospheric pressure and sinks into the skull cavity (sinking skin flap) once the brain swelling diminishes. Physiologic dynamics of the cerebrospinal fluid are deranged, leading to hydrocephalus, subdural hygromas and parenchymal effusions. This assumption is enforced by pathophysiological observations of decreased cerebral blood flow in both hemispheres following decompression, and normalization thereof following re-implantation of the bone flap. This pilot study aims at assessing feasibility of a change in surgical protocol. The rate of ICP control will be used to determine the sample size of a planned monocenter study. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04865757
Study type Interventional
Source University Hospital Inselspital, Berne
Contact
Status Completed
Phase N/A
Start date July 2012
Completion date September 2020

See also
  Status Clinical Trial Phase
Completed NCT02690454 - Which Platelet Function Test Best Reflects the In Vivo Plasma Concentrations of Ticagrelor and Its Active Metabolite? N/A
Completed NCT00564382 - CMR in the Assessment of Patient With ACS in the Emergency Room N/A
Completed NCT04462315 - 10-Years Follow-up of the EXAMINATION Trial
Recruiting NCT01823185 - Bedside Testing of CYP2C19 Gene for Treatment of Patients With PCI With Antiplatelet Therapy Phase 4
Completed NCT01749358 - Dose Optimization for Stroke Evaluation Phase 1
Recruiting NCT03230032 - Pacifier Activated Device and Mother's Voice in Infants at High-risk for Cerebral Palsy N/A
Active, not recruiting NCT02928198 - Bifurcation ABSORB OCT Trial N/A
Recruiting NCT04265664 - Telerehabilitation With Aims to Improve Lower Extremity Recovery Post-Stroke N/A
Terminated NCT02002234 - Hemicraniectomy for Malignant Middle Cerebral Artery Infarction (HeMMI) N/A
Completed NCT00001840 - Evaluation of Treated and Untreated Stroke N/A
Completed NCT01273467 - A Safety and Tolerability Study of 42037788 (Referred to as CNTO 0007) Compared With Placebo in Patients Who Have Experienced Ischemic Cerebral Infarction (Also Known as Stroke) Phase 1
Recruiting NCT04232163 - Arm Boot Camp Study: Evaluation of a Program to Increase Upper Limb Recovery After Stroke N/A
Completed NCT01395303 - Polymorphisms in the Vitamin D System and Health N/A